Our group previously proved the excellent targeting capability of α-conotoxin ImI to MCF-7 human breast cancer cells via active binding to α7-nAChR (Mei et al., 2015), while it is unknown whether ImI could be used as a targeting peptide guiding DDS to NSCLC cells. The gene discussed is CHRNA7; the disease is breast carcinoma.